Jade Therapeutics Overview
- Year Founded
-
2011

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.91M
Jade Therapeutics General Information
Description
Developer of polymer-based pharmaceutical products to treat eye diseases. The company is focused on development of ocular therapeutics that improves corneal healing following damage from disease or injury.
Contact Information
Website
www.jadetherapeutics.com
Formerly Known As
iTherapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 675 Arapeen Drive
- Suite 302
- Salt Lake City, UT 84108
- United States
Jade Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 07-Mar-2016 | $2.91M | 00.000 | Completed | Startup | |
3. Seed Round | 01-Jan-2015 | Completed | Startup | |||
2. Grant | 01-Dec-2014 | $725K | Completed | Startup | ||
1. Grant | 01-Jan-2013 | $150K | Completed | Startup |
Jade Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of polymer-based pharmaceutical products to treat eye diseases. The company is focused on development of ocula
Pharmaceuticals
Salt Lake City, UT
0.000
0000-00-00
000000&0
Jade Therapeutics Competitors (33)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY | 00000 | 00.000 | 000000000000 | 00.000 |
000000 00000 | Corporate Backed or Acquired | Princeton, NJ | 000 | 00000 | 000000&0 | 00000 |
000000000 00000000 | Formerly VC-backed | Alpharetta, GA | 00 | 00000 | 000000000 | 00000 |
0000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 00.000 | 00000000000 | 00.000 |
000000 000 | Formerly VC-backed | Cranbury, NJ | 000 | 00000 | 000000&0 | 00000 |
Jade Therapeutics Patents
Jade Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9782345-B2 | Ocular composition and method | Active | 17-Oct-2013 | 0000000000 | 00 |
US-20150157563-A1 | Ocular composition and method | Active | 17-Oct-2013 | 0000000000 | |
EP-2838511-B1 | Ocular drug delivery system | Inactive | 16-Apr-2012 | 000000000 | |
EP-2838511-A1 | Ocular drug delivery system | Active | 16-Apr-2012 | 000000000 | |
EP-2838511-A4 | Ocular drug delivery system | Active | 16-Apr-2012 | A61K45/06 | 0 |
Jade Therapeutics Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Barbara Wirostko MD | Chief Scientific Officer, Co-Founder & Board Member |
Jade Therapeutics Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Barbara Wirostko MD | Jade Therapeutics | Chief Scientific Officer, Co-Founder & Board Member | 000 0000 |
Jade Therapeutics Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Science Foundation | Government | 000 0000 | 000000 0 | ||
Salt Lake Life Science Angels | Angel Group | 000 0000 | 000000 0 |